Amicus Therapeutics Inc (FOLD)
9.55
+0.05
(+0.53%)
USD |
NASDAQ |
Nov 22, 10:34
Amicus Therapeutics Shareholders Equity (Quarterly): 178.82M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 178.82M |
| June 30, 2024 | 132.52M |
| March 31, 2024 | 130.69M |
| December 31, 2023 | 160.17M |
| September 30, 2023 | 133.24M |
| June 30, 2023 | 111.58M |
| March 31, 2023 | 102.57M |
| December 31, 2022 | 123.05M |
| September 30, 2022 | 132.56M |
| June 30, 2022 | 173.42M |
| March 31, 2022 | 238.62M |
| December 31, 2021 | 307.37M |
| September 30, 2021 | 376.63M |
| June 30, 2021 | 213.91M |
| March 31, 2021 | 250.90M |
| December 31, 2020 | 286.38M |
| September 30, 2020 | 320.27M |
| June 30, 2020 | 360.95M |
| March 31, 2020 | 402.59M |
| December 31, 2019 | 476.42M |
| September 30, 2019 | 548.27M |
| June 30, 2019 | 600.06M |
| March 31, 2019 | 451.67M |
| December 31, 2018 | 342.91M |
| September 30, 2018 | 410.95M |
| Date | Value |
|---|---|
| June 30, 2018 | 561.90M |
| March 31, 2018 | 521.62M |
| December 31, 2017 | 352.85M |
| September 30, 2017 | 409.68M |
| June 30, 2017 | 266.89M |
| March 31, 2017 | 310.78M |
| December 31, 2016 | 360.15M |
| September 30, 2016 | 336.56M |
| June 30, 2016 | 334.24M |
| March 31, 2016 | 311.63M |
| December 31, 2015 | 347.83M |
| September 30, 2015 | 378.76M |
| June 30, 2015 | 328.90M |
| March 31, 2015 | 104.01M |
| December 31, 2014 | 122.18M |
| September 30, 2014 | 43.28M |
| June 30, 2014 | 36.31M |
| March 31, 2014 | 31.08M |
| December 31, 2013 | 45.75M |
| September 30, 2013 | 26.49M |
| June 30, 2013 | 39.56M |
| March 31, 2013 | 53.34M |
| December 31, 2012 | 69.22M |
| September 30, 2012 | 76.76M |
| June 30, 2012 | 73.17M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
102.57M
Minimum
Mar 2023
476.42M
Maximum
Dec 2019
230.63M
Average
196.37M
Median
Shareholders Equity (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 74.21M |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Ionis Pharmaceuticals Inc | 662.47M |
| Arbutus Biopharma Corp | 106.89M |
| Krystal Biotech Inc | 885.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 786.56M |
| Total Liabilities (Quarterly) | 607.73M |
| Debt to Equity Ratio | 2.178 |
| Current Ratio | 3.152 |
| Net Debt Paydown Yield | 0.02% |